Glucose transporter expression in eutopic endometrial tissue and ectopic endometriotic lesions

Mc Kinnon, Brett; Bertschi, Dominic; Wotzkow, Carlos; Bersinger, Nick A.; Evers, Jakob; Mueller, Michael (2014). Glucose transporter expression in eutopic endometrial tissue and ectopic endometriotic lesions. Journal of molecular endocrinology, 52(2), pp. 169-79. Journal of Endocrinology 10.1530/JME-13-0194

[img] Text
169.full.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (472kB) | Request a copy

Endometriosis is an extremely prevalent disorder characterized by the growth of endometrial tissue at ectopic locations. Glycolysis is an energy-producing mechanism that occurs in almost all cells and requires an adequate uptake of glucose mediated by glucose transporter (GLUT) proteins. At present, however, very little is known about their expression in either the endometrium or the endometriotic lesions. The objective of this study was to examine the expression of SLC2A genes in the endometrium of women with and without endometriosis and in the matching ectopic tissue, and to confirm the presence of the GLUT proteins in ectopic lesions. There was a significantly higher expression of SLC2A3 and a significantly lower expression of SLC2A4 in women with endometriosis compared with those without. In women with endometriosis, the ectopic expression of SLC2A3, SLC2A4 and SLC2A5 was significantly higher than that observed in the matching eutopic tissue. GLUT1 protein expression was present in both epithelial and stromal cells and GLUT3 was confined to CD45-positive leukocytes. GLUT4 expression was strong in both ectopic epithelial and stromal cells and localized to the cellular membrane in epithelial cells. These results show that GLUT expression is altered between eutopic and ectopic tissue and between women with and without endometriosis, and that GLUT4 may represent a significant entry route for glucose into the endometriotic epithelial cells. The inducible nature of GLUT4 and its limited cellular expression may make GLUT4 an attractive target for non-hormone-based treatments of endometriosis.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Anatomy
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Gynaecology

UniBE Contributor:

Mc Kinnon, Brett; Bertschi, Dominic; Bersinger, Nick A.; Evers, Jakob and Mueller, Michael

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0952-5041

Publisher:

Journal of Endocrinology

Language:

English

Submitter:

Monika Zehr

Date Deposited:

17 May 2016 16:51

Last Modified:

17 May 2016 16:51

Publisher DOI:

10.1530/JME-13-0194

PubMed ID:

24412827

Uncontrolled Keywords:

GLUT4; SLC2A; endometriosis; endometrium; glucose

BORIS DOI:

10.7892/boris.48959

URI:

https://boris.unibe.ch/id/eprint/48959

Actions (login required)

Edit item Edit item
Provide Feedback